Planet 13 Holdings PLNH
OTC PLNH
$0.16 +0.01 (+5.63%)
As of: Aug 21, 2026 · 3:59 PM EDT

Planet 13 Holdings (PLNH) Liabilities and Shareholders Equity (2021 - 2026)

Planet 13 Holdings (PLNH) posted quarterly Liabilities and Shareholders Equity of $146.9 million for Q1 2026, down 27.91% year-over-year from $203.8 million in Q1 2025, and down 3.52% quarter-over-quarter from $152.3 million in Q4 2025.

Planet 13 Holdings (PLNH) Liabilities and Shareholders Equity (2021 - 2026) Analysis & Trends

Planet 13 Holdings (PLNH) has reported Liabilities and Shareholders Equity for 6 consecutive years, with $146.9 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Liabilities and Shareholders Equity fell 27.91% year-over-year to $146.9 million; the TTM figure through Mar 2026 stood at $658.7 million (down 26.48% YoY), while the FY2025 annual figure was $152.3 million, down 26.34% from the prior year.
  • Liabilities and Shareholders Equity slipped to $146.9 million in Q1 2026 per PLNH's latest filing, from $152.3 million in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $274.0 million in Q1 2022 and bottomed at $146.9 million in Q1 2026.
  • Historically, Liabilities and Shareholders Equity has averaged $204.1 million across 5 years, with a median of $206.7 million in 2023.
  • Annual changes were most pronounced in 2023 — Liabilities and Shareholders Equity plunged 38.46% — and 2024, when it soared 49.89%.
  • Planet 13 Holdings' Liabilities and Shareholders Equity stood at $220.1 million in 2022, then tumbled by 31.04% to $151.7 million in 2023, then jumped by 36.24% to $206.7 million in 2024, then decreased by 26.34% to $152.3 million in 2025, then slipped by 3.52% to $146.9 million in 2026.
  • Business Quant data shows PLNH's Liabilities and Shareholders Equity at $146.9 million in Q1 2026, $152.3 million in Q4 2025, and $158.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Haleon 44.51 Bn 43.55 Bn - 43.71 Bn
2 Teva Pharmaceutical Industries 43.52 Bn 39.86 Bn 2.15 Bn 39.86 Bn
3 Zoetis 32.43 Bn 30.75 Bn 1.05 Bn 15.08 Bn
4 Takeda Pharmaceutical 28.63 Bn 22.83 Bn 5.10 Bn 98.27 Bn
5 United Therapeutics 21.87 Bn 19.21 Bn 683.80 Mn 7.22 Bn
6 Viatris 18.98 Bn 18.09 Bn 1.46 Bn 35.04 Bn
7 Neurocrine Biosciences 15.43 Bn 15.04 Bn 935.80 Mn 5.36 Bn
8 Elanco Animal Health 12.02 Bn 11.49 Bn 798.00 Mn 13.56 Bn
9 Dr Reddys Laboratories 10.14 Bn 9.98 Bn - 6.18 Bn
10 Planet 13 Holdings 52.64 Mn 36.16 Mn 12.32 Mn 144.28 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 144.28 Mn
Mar 31, 2026 146.91 Mn
Dec 31, 2025 152.28 Mn
Sep 30, 2025 158.50 Mn
Jun 30, 2025 200.98 Mn
Mar 31, 2025 203.79 Mn
Dec 31, 2024 206.73 Mn
Sep 30, 2024 242.96 Mn
Jun 30, 2024 242.43 Mn
Mar 31, 2024 157.39 Mn
Dec 31, 2023 151.75 Mn
Sep 30, 2023 162.10 Mn
Jun 30, 2023 206.70 Mn
Mar 31, 2023 211.48 Mn
Dec 31, 2022 220.06 Mn
Sep 30, 2022 263.41 Mn
Jun 30, 2022 268.44 Mn
Mar 31, 2022 274.00 Mn
Dec 31, 2021 213.81 Mn